<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04865367</url>
  </required_header>
  <id_info>
    <org_study_id>2012-ABU-014-BL</org_study_id>
    <nct_id>NCT04865367</nct_id>
  </id_info>
  <brief_title>How Secreted-embryo-derived Trypsin Initiates, Maintains and Terminates Ca2+ Signals in Uterine Epithelial Cells</brief_title>
  <acronym>Ca2+</acronym>
  <official_title>To Investigate How Secreted-embryo-derived Trypsin Initiates, Maintains and Terminates Ca2+ (Intracellular Calcium) Signals in Uterine Epithelial Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ART Fertility Clinics LLC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Women's Hospital Tübingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ART Fertility Clinics LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To develop a deeper understanding of endometrial-embryo crosstalk through basic research,&#xD;
      uncover therapeutic targets and to improve reproductive outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pregnancy is a complex and highly coordinated physiological process that involves&#xD;
      implantation of a hatched blastocyst into a decidualizing endometrium. The main purpose of&#xD;
      implantation is to ensure that the blastocyst firmly anchors into the decidual stroma, which&#xD;
      allows further development by enabling placentation. Although a multitude of cellular events&#xD;
      and molecular pathways involved in embryo-uterine crosstalk have been identified in mouse&#xD;
      models, a comprehensive understanding of human embryo-uterine interaction is still missing.&#xD;
      Our work indicates that endometrial epithelial Ca2+ signalling in response to serine&#xD;
      proteases released by human embryos plays an important role in maternal recognition and&#xD;
      selection of the conceptus at implantation. Previous studies have demonstrated that&#xD;
      trophoblast spheroids can elevate [Ca2+]i in human uterine epithelial cell line (Ishikawa) by&#xD;
      activating Ca2+ entry via mechano-sensitive Ca2+ permeable channels leading to the induction&#xD;
      of epithelial adhesiveness. However, the mechanism(s) mediating the protease-induced [Ca2+]i&#xD;
      transients in human uterine epithelium have not been studied to date. Investigators&#xD;
      hypothesise that Na+ entry into the intravillous space via trypsin-activated ENaC will&#xD;
      depolarise the cellular membrane and increase [Na+]v sufficiently high to reverse the&#xD;
      sodium/calcium exchanger providing means for Ca2+ entry into the intravillous space. Ca2+&#xD;
      diffusion from the microvilli into the bulk cytoplasm will increase [Ca2+]i and, in parallel&#xD;
      with SOCE, act as a source for re-filling of the ER. Increased [Ca2+]i will also activate the&#xD;
      BK channels leading to repolarisation and termination of Ca2+ entry via the NCX.&#xD;
&#xD;
      By using spent medium from embryos, which will undergo pre-implantation genetic testing, it&#xD;
      will become possible to determine, whether the above mentioned mechanisms are influenced by&#xD;
      the ploidy status of the embryo.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in markers of protein</measure>
    <time_frame>1 day</time_frame>
    <description>Change in markers of protein (PAR2, (p) and SGK1, NFkB, ORAI1-3 and STIM1-2 and COX2) using Western blotting</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in peak and slope levels of intracellular calcium</measure>
    <time_frame>1 day</time_frame>
    <description>Change in peak and slope levels of intracellular calcium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in morphohology of cells after incubation with embryo media</measure>
    <time_frame>1 day</time_frame>
    <description>Change in morphohology of cells after incubation with embryo media</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performance of ICSI</measure>
    <time_frame>1 day</time_frame>
    <description>Defined on day 0 as the number of injected oocytes/number of COCs assigned to the ICSI group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo quality on day 3</measure>
    <time_frame>1 day</time_frame>
    <description>Defined by the number of blastomeres and their division pattern, fragmentation, presence of compaction, vacuoles, granulation and nuclei</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo quality on day 5 (Gardner and Schoolcraft,1999)</measure>
    <time_frame>1 day</time_frame>
    <description>Gardner and Schoolcraft,1999) defined by:&#xD;
The expansion stage of the blastocyst&#xD;
Quality of the ICM and TE&#xD;
Day on which the biopsy is performed (day 5,6 or 7)&#xD;
Pregnancy outcomes (miscarriages/ectopic pregnancy/neonatal outcome)</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Infertility</condition>
  <condition>Infertility, Female</condition>
  <condition>Aneuploidy</condition>
  <arm_group>
    <arm_group_label>DEG n1: euploid medium</arm_group_label>
    <description>culture media derived from euploid embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DEG n2: aneuploid medium</arm_group_label>
    <description>culture media derived from aneuploid embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DEG n3: medium arrested embryos</arm_group_label>
    <description>culture media derived from arrested embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DEG n4: control culture medium</arm_group_label>
    <description>pure culture media without contact to embryos</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exposure to culture media</intervention_name>
    <description>Exposure to culture media</description>
    <arm_group_label>DEG n1: euploid medium</arm_group_label>
    <arm_group_label>DEG n2: aneuploid medium</arm_group_label>
    <arm_group_label>DEG n3: medium arrested embryos</arm_group_label>
    <arm_group_label>DEG n4: control culture medium</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Arab ethnicity, with primary / secondary infertility, who undergo an ICSI treatment with&#xD;
        preimplantation genetic testing for aneuploidies.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Couples with primary / secondary infertility who are planned to undergo ICSI treatment&#xD;
             with PGT-A&#xD;
&#xD;
          -  Age of each partner above 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Couples with consanguinity (couple who is 1st or 2nd degree cousins)&#xD;
&#xD;
          -  Couples in whom the female partner has a history of:&#xD;
&#xD;
          -  Chemotherapy or radiation which impacts the ovarian reserve&#xD;
&#xD;
          -  Surgery at the ovaries / adnex region&#xD;
&#xD;
          -  Endometriosis&#xD;
&#xD;
          -  Couples in whom the male partner has a history of:&#xD;
&#xD;
          -  Chemotherapy / Radiation which impacts the semen result&#xD;
&#xD;
          -  Surgery at the testicles&#xD;
&#xD;
          -  Vasectomy&#xD;
&#xD;
          -  Surgery for reversal of vasectomy&#xD;
&#xD;
          -  Semen obtained by fine needle aspiration (FNA) or Testicular sperm extraction (TESE)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female arab</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BARBARA LAWRENZ, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ART Fertility Clinics LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>BARBARA LAWRENZ, PhD</last_name>
    <phone>97126528000</phone>
    <phone_ext>1108</phone_ext>
    <email>shieryl.digma@artfertilityclinics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>SHIERYL DIGMA, RN</last_name>
    <phone>97126528000</phone>
    <email>shieryl.digma@artfertilityclinics.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006 Mar;7(3):185-99. Review.</citation>
    <PMID>16485018</PMID>
  </reference>
  <reference>
    <citation>Kaneko Y, Day ML, Murphy CR. Integrin β3 in rat blastocysts and epithelial cells is essential for implantation in vitro: studies with Ishikawa cells and small interfering RNA transfection. Hum Reprod. 2011 Jul;26(7):1665-74. doi: 10.1093/humrep/der128. Epub 2011 Apr 30.</citation>
    <PMID>21531996</PMID>
  </reference>
  <reference>
    <citation>Mertzanidou A, Wilton L, Cheng J, Spits C, Vanneste E, Moreau Y, Vermeesch JR, Sermon K. Microarray analysis reveals abnormal chromosomal complements in over 70% of 14 normally developing human embryos. Hum Reprod. 2013 Jan;28(1):256-64. doi: 10.1093/humrep/des362. Epub 2012 Oct 9.</citation>
    <PMID>23054067</PMID>
  </reference>
  <reference>
    <citation>Teklenburg G, Salker M, Heijnen C, Macklon NS, Brosens JJ. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod. 2010 Dec;16(12):886-95. doi: 10.1093/molehr/gaq079. Epub 2010 Sep 16. Review.</citation>
    <PMID>20847090</PMID>
  </reference>
  <reference>
    <citation>Quenby S, Vince G, Farquharson R, Aplin J. Recurrent miscarriage: a defect in nature's quality control? Hum Reprod. 2002 Aug;17(8):1959-63. Review.</citation>
    <PMID>12151421</PMID>
  </reference>
  <reference>
    <citation>Aplin JD. Embryo implantation: the molecular mechanism remains elusive. Reprod Biomed Online. 2006 Dec;13(6):833-9. Review.</citation>
    <PMID>17169205</PMID>
  </reference>
  <reference>
    <citation>Zhang S, Lin H, Kong S, Wang S, Wang H, Wang H, Armant DR. Physiological and molecular determinants of embryo implantation. Mol Aspects Med. 2013 Oct;34(5):939-80. doi: 10.1016/j.mam.2012.12.011. Epub 2013 Jan 2. Review.</citation>
    <PMID>23290997</PMID>
  </reference>
  <reference>
    <citation>Ruan YC, Guo JH, Liu X, Zhang R, Tsang LL, Dong JD, Chen H, Yu MK, Jiang X, Zhang XH, Fok KL, Chung YW, Huang H, Zhou WL, Chan HC. Activation of the epithelial Na+ channel triggers prostaglandin E₂ release and production required for embryo implantation. Nat Med. 2012 Jul;18(7):1112-7. doi: 10.1038/nm.2771.</citation>
    <PMID>22729284</PMID>
  </reference>
  <reference>
    <citation>Rossier BC, Stutts MJ. Activation of the epithelial sodium channel (ENaC) by serine proteases. Annu Rev Physiol. 2009;71:361-79. doi: 10.1146/annurev.physiol.010908.163108. Review.</citation>
    <PMID>18928407</PMID>
  </reference>
  <reference>
    <citation>Marunaka Y, Niisato N. Effects of Ca(2+) channel blockers on amiloride-sensitive Na(+) permeable channels and Na(+) transport in fetal rat alveolar type II epithelium. Biochem Pharmacol. 2002 Apr 15;63(8):1547-52.</citation>
    <PMID>11996897</PMID>
  </reference>
  <reference>
    <citation>Salker MS, Hosseinzadeh Z, Alowayed N, Zeng N, Umbach AT, Webster Z, Singh Y, Brosens JJ, Lang F. LEFTYA Activates the Epithelial Na+ Channel (ENaC) in Endometrial Cells via Serum and Glucocorticoid Inducible Kinase SGK1. Cell Physiol Biochem. 2016;39(4):1295-306. doi: 10.1159/000447834. Epub 2016 Sep 8.</citation>
    <PMID>27606670</PMID>
  </reference>
  <reference>
    <citation>Singh Y, Shi X, Zhang S, Umbach AT, Chen H, Salker MS, Lang F. Prolyl hydroxylase 3 (PHD3) expression augments the development of regulatory T cells. Mol Immunol. 2016 Aug;76:7-12. doi: 10.1016/j.molimm.2016.06.003. Epub 2016 Jun 19.</citation>
    <PMID>27331863</PMID>
  </reference>
  <reference>
    <citation>Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER, Macklon NS, Fauser BC. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007 Mar 3;369(9563):743-749. doi: 10.1016/S0140-6736(07)60360-2.</citation>
    <PMID>17336650</PMID>
  </reference>
  <reference>
    <citation>Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, Steel JH, Christian M, Chan YW, Boomsma CM, Moore JD, Hartshorne GM, Sućurović S, Mulac-Jericevic B, Heijnen CJ, Quenby S, Koerkamp MJ, Holstege FC, Shmygol A, Macklon NS. Uterine selection of human embryos at implantation. Sci Rep. 2014 Feb 6;4:3894. doi: 10.1038/srep03894.</citation>
    <PMID>24503642</PMID>
  </reference>
  <reference>
    <citation>Turco MY, Gardner L, Hughes J, Cindrova-Davies T, Gomez MJ, Farrell L, Hollinshead M, Marsh SGE, Brosens JJ, Critchley HO, Simons BD, Hemberger M, Koo BK, Moffett A, Burton GJ. Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nat Cell Biol. 2017 May;19(5):568-577. doi: 10.1038/ncb3516. Epub 2017 Apr 10.</citation>
    <PMID>28394884</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2021</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ART Fertility Clinics LLC</investigator_affiliation>
    <investigator_full_name>Barbara Lawrenz</investigator_full_name>
    <investigator_title>Scientific Director</investigator_title>
  </responsible_party>
  <keyword>IVF</keyword>
  <keyword>RNA</keyword>
  <keyword>Ca2+</keyword>
  <keyword>embryo</keyword>
  <keyword>media</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
    <mesh_term>Aneuploidy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

